M2-Macrophage-Derived Exosomes Promote Meningioma Progression through TGF-β Signaling Pathway

Xiao-Hong Fu1, Jian-Ping Li2, Xue-Ying Li1

  • 1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Insights

Tumor-associated macrophages (TAMs) release exosomes that promote meningioma growth. Targeting these exosomes and the TGF-β pathway may offer new therapeutic strategies for meningioma patients.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Tumor-associated macrophages (TAMs) are key in the tumor microenvironment, aiding cancer progression.
  • The role of TAMs in meningioma development is not fully understood.
  • This study investigates M2-polarized macrophage-derived exosomes (M2-MDEs) in meningioma.

Purpose of the Study:

  • To explore the role of M2-MDEs in meningioma tumorigenesis and progression.
  • To identify the molecular mechanisms by which M2-MDEs influence meningioma cells.
  • To assess the therapeutic potential of targeting M2-MDEs.

Main Methods:

  • Immunohistochemistry to analyze macrophage phenotypes in meningioma tissues.
  • Cell coculture and RNA sequencing to study M2-MDE effects on meningioma cells.
  • 3D tumorsphere and xenograft models to evaluate tumorigenesis and development.

Main Results:

  • M2 macrophages are abundant in meningioma tissues, and M2-MDEs promote proliferation, migration, and invasion.
  • Bioinformatic analysis revealed TGF-β pathway activation in meningioma cells treated with M2-MDEs.
  • Inhibition of the TGF-β pathway reversed the tumor-promoting effects of M2-MDEs.

Conclusions:

  • M2-MDEs enhance meningioma development and invasion via TGF-β pathway activation.
  • Exosome-mediated communication is a potential therapeutic target for meningioma.
  • Targeting M2-MDEs could represent a novel strategy for meningioma treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K